Comfort First Anti Human Cd40 Flow Cytometry Monoclonal Clone 3a8 Pe Ready To Use Grab It Now [Tm2suyYe]

Comfort First Anti Human Cd40 Flow Cytometry Monoclonal Clone 3a8 Pe Ready To Use Grab It Now [Tm2suyYe]

The Comfort First Anti Human Cd40 Flow Cytometry Monoclonal Clone 3a8 Pe Ready To Use Grab It Now [Tm2suyYe] from Innovative Research is a cutting-edge flow cytometry antibody designed for precise and efficient analysis. This product is meticulously formulated to offer researchers a streamlined workflow, ensuring consistent and reliable results. With its ready-to-use format, this antibody is an ideal choice for laboratories seeking to enhance their flow cytometry assays.

Key Features and Specifications

• Host Species: Mouse
• Target Species: Human
• Target: CD40
• Isotype: Mouse IgG2a, Kappa
• Clonality: Monoclonal
• Clone: 3A8
• Conjugation: PE
• Buffer: PBS with 0.05% Proclin300, 1% BSA
• Concentration: Ready To Use

The inclusion of Proclin300 and BSA in the buffer ensures stability and compatibility with various flow cytometry assays. This antibody is fully optimized for use with Innovative Research's flow cytometry isotype controls, providing a comprehensive solution for researchers looking to validate their assays and control for non-specific binding.

Practical Applications and Benefits

This ready-to-use antibody is an essential tool for researchers in immunology, oncology, and other fields where CD40 expression is of interest. Its specificity and ease of use make it a valuable asset for both routine and complex experiments. By utilizing this monoclonal clone, scientists can achieve accurate and reproducible results, saving time and resources. With its broad compatibility and superior performance, the Comfort First Anti Human Cd40 Flow Cytometry Monoclonal Clone 3a8 Pe Ready To Use Grab It Now [Tm2suyYe] is a must-have for any laboratory engaged in flow cytometry research. For further information and to explore additional isotype controls, please visit our website. Remember, for research use only.